If you have been reading about Preclinical research and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-03. Numbers and descriptions here follow the published literature rather than marketing material.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport; not approved as medicine | Listed by WADA at all times. |
| Common synonyms | GW501516, GW-501516, endurobol | Cardarine is a colloquial name. |
| Typical analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Common test matrix | Urine | Blood and dried blood spots also possible. |
| Legal classification | Varies by country | Often treated as unapproved drug or research chemical. |
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
=== Screening glucose challenge test === The screening glucose challenge test (sometimes called the O'Sullivan test) is performed between 24 and 28 weeks and can be seen as a simplified version of the oral glucose tolerance test (OGTT). No previous fasting is required for this screening test, in contrast to the OGTT. The O'Sullivan test involves drinking a solution containing 50 grams of glucose and measuring blood levels one hour later. If the cut-off point is set at 140 mg/dL (7.8 mmol/L), 80% of women with GDM will be detected. If this threshold for further testing is lowered to 130 mg/dL, 90% of GDM cases will be detected, but there will also be more women who will be subjected to a consequent OGTT unnecessarily.
=== Grafting polymers onto and/or from surfaces === Antimicrobial activity can be imparted onto a surface through the grafting of functionalized polymers, for example, those terminated with quaternary amine functional groups, through one of two principle methods. With these methods—"grafting to" and "grafting from"—polymers can be chemically bound to a solid surface and thus the properties of the surface (i.e. antimicrobial activity) can be controlled. Quaternary ammonium ion-containing polymers (PQA) have been proven to effectively kill cells and spores through their interactions with cell membranes. A wealth of nitrogenous monomers can be quaternized to be biologically active. These monomers, for example 2-dimethylaminoethyl methacrylate (DMAEMA) or 4-vinyl pyridine (4-VP) can be subsequently polymerized with ATRP. Thus antimicrobial surfaces can be prepared via "grafting to" or "grafting from" mechanisms.
Large farms: When a digital agriculture technology requires much upfront investment, only large farms with sufficient assets and credit access will adopt it. For example, large farms are most likely to adopt precision agriculture technologies because of high costs. Increasingly however, automated mechanization is focusing on more but smaller autonomous machines, instead of fewer but larger machines such as observed with machines that still require human control. This trend enables smaller farms to participate in digital agriculture more evenly with larger farms, as the upfront investment becomes more equal relative to the size of the farm. Digital divide: The uneven access to information and communication technologies (ICTs) may lead to uneven adoption of, and thereby uneven gains from, digital agriculture. When digital technologies require specific skills, benefits may accrue to digitally literate farmers positioned to take advantage of such opportunities. Gender: Given gender-based disparities in ICT access and the gender gap in agribusiness value chains, men seem more likely to adopt digital agriculture. Therefore, digital technologies could perpetuate gender inequalities in the agricultural sector. Unskilled labor: Advances in on-farm productivity, particularly through digitized automation and precision agriculture, may threaten low-skilled jobs. According to the OECD, agriculture will be one of the sectors most affected by automation and McKinsey Global Institute projects that automation will displace 15% of agricultural workers in Mexico and 30% in Germany.
It may lead to brain tumors such as astrocytomas. In some of the late-onset neurodegenerative diseases that share aggregation of misfolded proteins as a common feature, such as Parkinson's disease and Alzheimer's disease, large insoluble aggregates of misfolded proteins can form and then result in neurotoxicity, through mechanisms that are not yet well understood. Decreased proteasome activity has been suggested as a cause of aggregation and Lewy body formation in Parkinson's. This hypothesis is supported by the observation that yeast models of Parkinson's are more susceptible to toxicity from α-synuclein, the major protein component of Lewy bodies, under conditions of low proteasome activity. Impaired proteasomal activity may underlie cognitive disorders such as the autism spectrum disorders, and muscle and nerve diseases such as inclusion body myopathy.
Sources: en.wikipedia.org
=== March === 6 March Astronomers report the discovery of GJ 887 d, a super-Earth exoplanet orbiting the nearby red dwarf star GJ 887. Detected using radial velocity measurements, the planet lies within the star's habitable zone. At just 10.7 light-years, this becomes the second-nearest known exoplanet in the habitable zone after Proxima Centauri b. The UK's first long‑distance robotic-assisted surgery is reported to have been performed on a patient located 1,500 miles (2,400km) away in Gibraltar. 9 March – A study published in Geophysical Research Letters reports with statistical confidence that global warming has accelerated since around 2015, with the rate of increase rising from 0.2 °C to about 0.35 °C per decade after accounting for natural variability. The findings suggest the 1.5 °C threshold could be reached before 2030 if current trends continue. 10 March – A study by Vattenfall and Spoor using AI-assisted video monitoring of 2,007 bird flight paths near an offshore turbine at Aberdeen Bay over 19 months reports no confirmed collisions, with observed avoidance behaviour suggesting lower-than-expected impacts of wind turbines on seabirds. 11 March Two separate studies, published in Environmental Research Letters and Nature Communications, show how net negative emissions will need to be sustained for centuries in order to stabilise global climate change. Astronomers report evidence of a likely collision between two planets orbiting the star Gaia20ehk, about 11,000 light years away in the constellation Puppis.
IonSense, Inc. is a Massachusetts-based company that is developing technology for the analysis of materials by direct analysis in real time or DART mass spectrometry. DART MS provides rapid qualitative and quantitative sample analysis of bioanalytical, medicinal, forensic, and chemical synthesis products by ambient mass spectrometry. IonSense provides the DART Ion Sources which are interfaced to mass spectrometry systems manufactured by JEOL, Thermo Fisher Scientific, Bruker, Applied Biosystems, Agilent, and Waters. IonSense was acquired by Bruker in April 2022.
Similarly to the SIR model, also, in this case, we have a Disease-Free-Equilibrium (N,0,0,0) and an Endemic Equilibrium EE, and one can show that, independently from biologically meaningful initial conditions
29 September The kārearea is named Bird of the Year for 2025. The government announces a reform of the earthquake-prone building classification system which reduces the amount of buildings nationwide being classed as earthquake-prone by 55%. 30 September: Carter Holt Harvey confirms plans to close its Tokoroa plywood plant in November 2025, affecting 119 jobs. A measles case linked to international travel is reported in Queenstown, bringing the total number of cases to five.
== SPE and chromatography == SPE is in fact a method of chromatography, in the sense of having a mobile phase, carrying mixtures through a stationary phase, packed inside a column. The chromatographic process is harnessed to create a solid-liquid extractive technique—allowing separation of a mixture of components by taking advantage of large differences between the solid and liquid phase Keq, or equilibrium constant, for each component in the mixture. The chemical considerations for the selection of stationary and mobile phases are similar to those for liquid column chromatography and many of the adsorbents/materials used are the same. The theory, procedures, and aims are different, however, and as an extractive technique it has a unique niche in modern chemical science.
Sources: en.wikipedia.org
Most children with progeria appear normal at birth and during early infancy. Children with progeria usually develop the first symptoms during their first few months of life. The earliest symptoms may include a failure to thrive and a localized scleroderma-like skin condition. As a child ages past infancy, additional conditions become apparent, usually around 18–24 months. Limited growth, full-body alopecia (hair loss), and a distinctive appearance (a small face with a shallow, recessed jaw and a pinched nose) are all characteristics of progeria. Signs and symptoms of this progressive disease tend to become more marked as the child ages. Later, the condition causes wrinkled skin, kidney failure, loss of eyesight, and atherosclerosis and other cardiovascular problems. Scleroderma, a hardening and tightening of the skin on trunk and extremities of the body, is prevalent. People diagnosed with this disorder usually have small, fragile bodies, like those of older adults. The head is usually large relative to the body, with a narrow, wrinkled face and a beak nose. Prominent scalp veins are noticeable (made more obvious by alopecia), as well as prominent eyes. Musculoskeletal degeneration causes loss of body fat and muscle, stiff joints, hip dislocations, and other symptoms generally absent in the non-elderly population. Individuals usually retain typical mental and motor function.
=== Cardiovascular === Agmatine produces mild reductions in heart rate and blood pressure, apparently by activating both central and peripheral control systems via modulation of several of its molecular targets including: imidazoline receptors subtypes, norepinephrine release and NO production.
=== Transgenic plant and animals === In recent years, expression vectors have been used to introduce specific genes into plants and animals to produce transgenic organisms, for example in agriculture it is used to produce transgenic plants. Expression vectors have been used to introduce a vitamin A precursor, beta-carotene, into rice plants. This product is called golden rice. This process has also been used to introduce a gene into plants that produces an insecticide, called Bacillus thuringiensis toxin or Bt toxin which reduces the need for farmers to apply insecticides since it is produced by the modified organism. In addition expression vectors are used to extend the ripeness of tomatoes by altering the plant so that it produces less of the chemical that causes the tomatoes to rot. There have been controversies over using expression vectors to modify crops due to the fact that there might be unknown health risks, possibilities of companies patenting certain genetically modified food crops, and ethical concerns. Nevertheless, this technique is still being used and heavily researched. Transgenic animals have also been produced to study animal biochemical processes and human diseases, or used to produce pharmaceuticals and other proteins. They may also be engineered to have advantageous or useful traits. Green fluorescent protein is sometimes used as tags which results in animal that can fluoresce, and this have been exploited commercially to produce the fluorescent GloFish.
== Role in disease == A defect in the degradation of glucocerebrosides is Gaucher's disease. The corresponding defects for galactocerebrosides are: a) Ceramide trihexoside (globotriaosylceramide) accumulation – Fabry's disease. Clinical features include acroparaesthesia (tingling, pins and needles sensation in the extremities) b) Galactocerebroside (galactosylceramidase) accumulation – Krabbe disease.
6 August Weather Forecast about weather forecasting in the UK; Swedish Lennart Bengtsson of the European Centre for Medium-Range Weather Forecasts; Alistair Woodroffe and Brian Webster of the Met Office; numerical calculations began in the early 1950s with computers making 10,000 calculations a second but by the mid-1980s it was one billion; Meteosat-2 launched in June 1981; Steven Burke of the London Potato Futures Association; Capt Derek Ralph in a British Caledonian BAC One-Eleven flying to Aberdeen Airport; amateur weatherman Bill Foggitt; the weather centre and Lockheed C-5 Galaxy aircraft at RAF Mildenhall; conservationist Robin Page; narrated by Muriel Gray, directed by John Dollar, made by Uden Associates 13 August Made to Measure, essentially a re-edited, slightly updated edition of the August 1986 episodes on the F1 Ford turbocharged engine, with a few minutes of new content; in May 1987 Peter Collins watches the previous San Marino Grand Prix; Ford Cosworth V6 B187 cars: engine mapping; Dick Scammel, general head of engineering; Martin Walters, chief development engineer; the engine is dismantled, and damage is found; Geoff Goddard, chief racing engine designer; electromagnetic pulses from the engine affected the working of the engine computer circuitry; rogue signals were picked up by the engine computer, so causing erratic fuel injection; French F1 driver Patrick Tambay listens to the sound of the turbo; the turbo pressure would be limited to 2.5 in 1988, before turbos were banned for the 1989 season; the Italian Grand Prix circuit; each team is allowed two sets of qualifying tyres; the tyres on the rear axle warm up before the front axle; the Honda V6 engine could produce 1200 hp; chief designer Rory Byrne, and F1 aerodynamic forces. Narrated mostly by Martin Jarvis and partly by Eleanor Bron 20 August Twang, Bang, Kerang!, about the electric guitar; the Fat Tuesdays night club, and Les Paul; Glenn Wilson of the Institute of Psychiatry in London; Louis Jordan in the late 1940s; Charlie Christian developed the Gibson-ES150; Steve Howe of Yes; Burns London manufacturing guitars; Dave Russell; the body of the guitar was made of maple, a tonewood, and the fretboard of rosewood; the sound originates from the type of wood; Jerry Donohue of Fairport Convention; pickups made by Seymour Duncan; Chet Atkins; Andy Summers of The Police and Every Breath You Take; Francis Dunnery of It Bites, and Once Around the World. Narrated by John Hedges, produced by Patrick Uden, directed by Jeremy Llewellyn-Jones, made by Uden Associates 27 August What Goes Up..., about dismantling the AGR at Sellafield; it featured Tom Marsham CBE FRS (10 November 1923 – 12 October 1989) of UKAEA at Risley, Warrington (Birchwood Park), who was the reactor manager of Calder Hall in 1956. Narrated by Sue Jay, produced by Michael Blakstad, made by Workhouse Productions 3 September Hole in the Sky, about the depletion of the ozone layer, with Sir Bob Watson at NASA; the NERC's British Antarctic Survey had been measuring ozone levels since 1957 at the Halley Research Station, and a team led by Joe Farman noticed a hole in the layer; NASA had not noticed an ozone hole on its Nimbus 7 satellite, although the satellite had picked up all of the data, as Richard Stolarski of the Goddard Space Flight Center found; the ozone hole was caused by the polar vortex over the winter, where air movements outside of Antarctica are trapped, and there is not enough light to form new ozone; some people believed that the 1982 Mexican El Chichón volcanic eruption was to blame; in 1974 F. Sherwood Rowland and Mario Molina of the University of California, Irvine found that some chlorine compounds would destroy ozone by making chlorine monoxide, and both received the 1995 Nobel Prize in Chemistry for this discovery; the Chemical Manufacturers' Association (since 2000 the American Chemistry Council) and the National Science Foundation launched a new atmospheric survey at McMurdo Station, led by Susan Solomon of the Earth System Research Laboratories; Jerry D. Mahlman of the Geophysical Fluid Dynamics Laboratory at Princeton was attempting a computer model of the Antarctic atmosphere; Rafe Pomerance of the World Resources Institute; the greenhouse effect, described by James Hansen of the Goddard Institute for Space Studies, who claimed that the Earth's temperature would be 2 degrees higher by 2000, 3 degrees higher by 2010, and 4 to 7 degrees warmer by 2030; Richard E. Benedick. Directed by Linda Harrar, produced by Paula Apsell, made by WGBH, Uden Associates, Television Trust for the Environment and Sveriges Television. Originally a Nova documentary 24 September Dirty Money, about whether the environment can be cleaned up; the UK's first anti-pollution trade fair in March 1987, attended by William Waldegrave; Father Jim Conlon and Portglenone Abbey in N Ireland, with an anaerobic digester, which saved £1000 a month in gas cost, and the manure was sold for £25,000 a year; Mike Flux of ICI; biologist Paul Johnston of Greenpeace, in Teesside; the River Tees was the second-most polluted in the UK, with Douglas Ord of Northumbrian Water; Ken Murphy, and how Greenpeace attempted to block an effluent pipe near Immingham in March 1985; John Elkington, environmental writer; BioTechnica of Llanishen in Cardiff, reclaiming contaminated land on a former highly polluted gasworks site in Lancashire; Jutta Ditfurth; Hans-Georg Peine of BASF AG, and the Sandoz chemical spill in November 1986 in Switzerland; in 1983, ICI founded the first bioplastic company, called Marlborough Biopolymers, which made polyhydroxy butyrate; Dame Anita Roddick of The Body Shop, who worked with Friends of the Earth; Peter Baylis of the NERC Environmental Satellite Laboratory, which began in 1975, in the University of Dundee's Ewing Building, and largely provided the only UK archive of satellite environmental data. Narrated by Bob Peck, produced by Edward Poulter, directed by David Sharp, made by London Scientific Films 1 October Malltime. A US production, produced by Mike Wallington, made by George Haggerty, made by Kai Productions 8 October Anything You Can Do..., about new robotics; the five houses puzzle; Richard Gregory, professor of neuropsychology at the University of Bristol; Roger Mathias of Plessey Radar and the Multi-function Electronically Scanned Adaptive Radar (MESAR), began in 1982; Henry Thompson and speech recognition at the School of Informatics, University of Edinburgh; Robert Kowalski of the Department of Computing, Imperial College London; Margaret Boden of the University of Sussex; J. Michael Brady; Paul Caplin and robotics; Roy Bottomley of Meiko Scientific, and the transputer, developed in the UK; Plessey Laboratories at the Allen Clark Research Centre, and new chemical compounds for computer chip; logic programming and heuristics; the European Eureka Prometheus Project, an expert system. Narrated by Miriam Margolyes, produced by Michael Blakstad, directed by Catherine Robins, made by Workhouse Productions 22 October Command and Control, the chain of command of nuclear weapons; it featured the Air Force Research Laboratory. Directed by Clive Syddall, made by Twenty Twenty Vision 5 November Earthquake Country, about the San Andreas fault; Robert Wallace, chief scientist of the USGS; the 1906 earthquake caused the tectonic planes to move around seven metres; geologist Grove Karl Gilbert; an earthquake in the middle section of the fault was expected for around 1988; a 5.8 earthquake on 8 June 1934; geologist Kerry Sieh and paleoseismology; if an earthquake took place, coordination would be from the Joint Forces Training Base - Los Alamitos; earthquake engineer George W. Housner of Caltech; structural engineer Ray William Clough; earthquake engineer Luis Estava Maraboto of the Engineering Institute of the National Autonomous University of Mexico. Produced by Arabella Woods, directed by John Tchalenko, made by Red Rooster Films 12 November Nature's Technology, about the different types and the modelling of animal locomotion, and legged robots; robotic hands and bioengineer Stephen Jacobsen of the University of Utah; snake-arm robots; the 1986 Adaptive Suspension Vehicle (ASV) of Ohio State University, a hexapod robot, and Vincent Vohnout; active balance and Marc Raibert; the 1965 Walking Truck of General Electric; static stability and the Odex 1 six-legged robot; biomechanics and Robert McNeill Alexander, Professor of Zoology; WABOT-2 of Waseda University, optical music recognition and the NHK Symphony Orchestra of Japan conducted by Yuzo Toyama. Narrated by Adrienne Posta, directed by David Barlow, produced by Karl Sabbagh, made by InCA 19 November Britain Can Make It?, about making kitchen units in the UK and in Germany; the dual system of apprenticeship in Germany; Sig Prais of the National Institute of Economic and Social Research; the Britain Can Make It exhibition, where the fitted kitchen was first introduced in the UK; the Hungarian designer George Fejer was largely responsible for introducing fitted kitchens; Wolfgang Luckhaus of Poggenpohl of Germany, which also developed the fitted kitchen; in the 1960s the Germans introduced chipboard for kitchen manufacturing, which became industry-standard, with wipe-clean melamine resin facing (MFC); Hilary Steedman of the NIESR, and how the Germans built kitchens to order, whereas British companies simply built kitchens, whether ordered or not; Heal's of London introduced German kitchens to the UK in the early 1970s, in a hausfest; the German SieMatic kitchen company; Doug Gregory started The Symphony Group in 1970 after seeing chipboard, developing flatpack kitchen units, the Germans did not make flatpack kitchens, only assembled kitchens; David Love, buying director of MFI, which was helped by the flatpack revolution, but it was all largely an imitation of German products, and was a mostly standard product range; Symphony introduced computer production control in the 1980s, which the Germans had introduced in the early 1970s - this allowed much more variation of manufacturing to order, which was the main German method; employees of Symphony were largely unskilled, but German workers were largely skilled apprentices, who had passed exams in manufacturing; nearly all of German kitchens were built to order, so needed skilled workers; Walter Siekmann, production manager of Poggenpohl; German furniture manufacture was found in East Westphalia (Ostwestfalen); the Germans believed in more thorough technical training, and sold their products all over the world, but British companies had less-thorough training, and did not sell as worldwide as the Germans. Narrated by John Woodvine, directed by David Habakkuk, made by Riverside Television 26 November At the Edge, about the physical limits placed upon fighter pilots when flying high G capable modern aircraft, such as the F16 and the F18. Pilots are subjected to G-LOC in the Aerospace Medicine centrifuge in San Antonio, Texas. Narrated by Ray Brooks, written, produced and directed by Chris Haws, made by InCA
Sources: en.wikipedia.org
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.
Laboratories use liquid chromatography-tandem mass spectrometry to detect GW501516 and its metabolites. Urine is commonly tested, and testing can occur in and out of competition.
No, cardarine is not a SARM. It is a PPARδ agonist, which acts on a different receptor. The two classes are often confused in online discussions.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.